Interactive webapp about centrally authorised medicines and their assessments (EPARs), updated at least once a week
Information on medicines and assessments
Category: EMA
Cancer medicines for children
A continually updated list of centrally authorised products (updated 2025-10-18)
Regulatory science, Drug development tools (DDTs)
A list of tools such as biomarkers, simulation approaches, new endpoints, novel methods, commented by regulatory agencies, updated daily
PIPs – Paediatric medicines investigations
A searchable webapp showing details of development plans (PIPs), updated at least once a week
Adult cancer medicines: starting trials with children
Many are relevant to be studied in children with cancer (updated 2022-04-24)Development going beyond rare adult tumour
Examples of medicines with development for children triggered by melanoma in adults (updated 2021-12-30)